Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis to Use GeneGo Software for Functional Analysis Service

NEW YORK (GenomeWeb News) — Genomic services firm Expression Analysis will use GeneGo’s 1-2-3-Workflow technology to provide functional analysis of pathways and networks as add-on services, GeneGo said today.
 
Under the multi-year agreement, Expression Analysis will submit to GeneGo data from various customers, including pharmaceutical companies, biotechs, and academic institutions, Julie Bryant, GeneGo’s vice president of business development and marketing, said in a statement.
 
GeneGo’s 1-2-3-Workflow compares multiple expression datasets, conducts enrichment analyses in multiple areas such as disease, pathways, and processes, and provides other analytical services. It returns these data in a Microsoft Word document within 24 hours.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.